HRH. Bernd Reith

H. Bernd Reith

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


H. Bernd Reith has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of the LT-α (+250 G/A) Polymorphism on Markers of Inflammation and Clinical Outcome in Critically Ill Patients

    by Sonja K. Rauchschwalbe, Thomas Maseizik, Ulrich Mittelkötter, Bernhard Schlüter, Christian Patzig, Arnulf Thiede, H. Bernd Reith

    Background: Tumor necrosis factor alpha as a central mediator of the inflammation cascade is correlated to sepsis outcome. Tumor necrosis factor beta (LT-α) binds the same cell receptor and polymorphisms in both genes have been described. To evaluate the importance of the LT-α (+250 G/A) polymorphism for the clinical outcome of patients developing postsurgical sepsis, 85 patients were consecutively included into this study. Methods: Blood samples were obtained for analysis of the biallelic LT-α (+250 G/A) polymorphism and for determination of serum levels of sTNF-R1, TNF-α, IL-6, IL-8, IL-10, procalcitonin, and neopterin. Cytokine levels were measured repeatedly until the patients’ discharge from the ICU. Results: The allele frequency was 0.28 for TNFB1 and 0.72 for TNFB2. The genotype distribution was TNFB1 homozygotes 4/79 (5.1%), TNFB1/TNFB2 heterozygotes 37/79 (46.8%), and TNFB2 homozygotes 38/79 (48.1%). Fifty-four out of 80 (67.5%) fulfilled the criteria for severe sepsis; 36/80 (45.0%) developed septic shock. Multiple organ failure occurred in 60/80 patients (75.0%), and the overall mortality was 26/80 (32.5%). Concerning the LT-α-genotypes, there was no difference in the frequency of severe sepsis or shock or in the development of multi-organ failure or death between the three subgroups. The peak plasma TNF-α levels were similar for all genotype subgroups. Conclusions: There was no correlation between the biallelic LT-α (+250 G/A) polymorphism and the outcome of critically ill patients. Genotyping this locus does not seem to be useful in predicting sepsis outcome.


    • 1 September 2003
      • Vol. 128  (9) , W88

    [Surgical infections].

    by H B Reith, S Rauchschwalbe, F Endter, A Thiede

  • Welche Auswirkungen wird die Einführung von G-DRGs auf chirurgische Abteilungen haben?

    by H. B. Reith

    Durch die geplante Einführung von Diagnosis related groups (DRG) in das stationäre Vergütungssystem der Krankenhäuser wird die „ökonomische Bremse” angezogen. Bei der steigenden Altersstruktur unserer Bevölkerung und gleichzeitig einhergehenden therapeutischen Verbesserungen gelingt es nicht mehr, allen Anforderungen einer umfassenden Gesundheitsbehandlung zu genügen. Mit der Einführung wird als wesentliches Merkmal der pauschalierte Erlös für einen Krankheitsfall initiiert, dies erfordert noch besseren Umgang mit den vorhandenen Ressourcen und eine Gratwanderung zwischen medizinischem und ökonomischem Denken. Als kurzfristige Konsequenz wird die systematische Erfassung von Diagnosen und Prozeduren zu einer unabdingbaren Voraussetzung für jede Abteilung um zu überleben. Strategische Entwicklungen und Zukunftsplanung ergeben dann mittelfristig Umstrukturierungen der Abteilungen, im Sinne von „klinischen Behandlungspfaden” oder auch als Leistungseinschränkung oder Ausweitung. With the planned introduction of Diagnosis related groups (DRG) in the German in-patient reimbursement system an economic brake will be put on the hospitals. The upcoming expected growth of the older German population and the ongoing process of better diagnostic and therapeutic procedures leads to a gap between costs and resources in the established health care system. With the introduction of the DRGs starts a process of one payment for one main diagnosis in hospital care. This requires a better resource control and leads to a tightrope walk between medical and economic aspects. The short time consequences result in great efforts of correct coding of diagnoses and procedures, as a survival strategy for surgical departments. More or less are new structures necessary, the development of “clinical pathways” and the increase or decrease of capacities will become the main tasks in the next years.


    • 1 May 2001
      • Vol. 20, 4957-60

    Improved sensitivity of fuzzy logic based tumor marker profiles for diagnosis of pancreatic carcinoma versus benign pancreatic disease.

    by U Halm, N Rohde, R Klapdor, H B Reith, A Thiede, G Etzrodt, J Mössner, T Keller

    The definite diagnosis of pancreatic tumors of unknown origin remains a clinical challenge. Imaging techniques may fail to differentiate malignant tumors from inflammation, especially in chronic pancreatitis. In a considerable number of cases, the definitive diagnosis needs laparotomy. Single tumor markers as CA 19-9 or CEA are of limited value in these cases because of their limited sensitivity and specificity. This study was performed to find out, whether a classification method based on fuzzy logic analysis of tumor marker profiles is feasible in patients with pancreatic carcinoma and benign pancreatic disease. Tumor markers and other clinical and laboratory parameters of 74 consecutive patients, either with histologically proved pancreatic carcinoma (n = 43) or presumed benign pancreatic disease (n = 31) assessed by ultrasound, endoscopic retrograde pancreatography, or computed tomography were analysed in order to detect their diagnostic value in the multi-dimensional approach of fuzzy logic analysis. Given a specificity of 95%, sensitivity was considerably increased by the fuzzy logic method (83%) compared with the best single tumor marker CA 19-9 (65%). CA 19-9, CYFRA 21-1 and CA 15-3 gave the most considerable contributions to the classification system, whereas CEA, CA 125, CA 72-4, AFP, liver enzymes, lipase, amylase, bilirubin, and ferritin were of no or little value. Tumor marker profiles analysed with the fuzzy logic method may have an improved sensitivity compared with single standard tumor markers. The diagnostic efficacy should be proved in patients with pancreatic tumors of unknown origin.


  • Procalcitonin (PCT) in patients with abdominal sepsis

    by H. B. Reith, U. Mittelkötter, R. Wagner, A. Thiede

    To assess the accuracy of procalcitonin as a measure of severity in patients with septic abdominal illnesses and the sepsis syndrome, to compare measurements with those of other inflammatory mediators, and to predict outcome.


    • 1 January 2000
      • Vol. 125  (2) , 111-22

    [Measures for allogeneic blood conservation in surgery].

    by B Mansouri Taleghani, R Grossmann, H B Reith, D Wiebecke, A Thiede

    The aim of all efforts to reduce the need of allogeneic blood transfusions is to avoid associated risks. There should particularly be a favourable effect according to the rate of transfusion-transmitted virus infections and immunological side-effects. The acceptance of an individually adjusted lowest haematocrit level and the minimisation of intra-operative blood loss by the application of optimal surgical techniques are among the most essential strategies to reduce or even avoid allogeneic blood transfusions. In addition the following interventions are generally accepted: Preoperative autologous blood donation, where appropriate supported by erythropoietin Preoperative haemodilution, where appropriate supported by erythropoietin Intra- and postoperative blood salvage Topical or systemic pharmacologic interventions to accelerate haemostasis Controlled hypotension Efficacy and indication of the different measures always depend on the individual circumstances of the specific patient. Therefore one should develop an individual approach for every case. In this context the most important subjects are an optimal coordination and if required an appropriate combination of the discussed methods. Algorithms which preoperatively allow approximate calculation of expected transfusion need may be a meaningful tool to facilitate blood conservation planning. However, at the same time one must consider that all strategies to reduce allogeneic transfusion needs are also associated with particular risks. Therefore one has to weigh carefully the pros and cons prior to their application, including the possible alternative of allogeneic transfusion in one's decision making process.

    • 1 January 2000
      • Vol. 125  (4) , W23-30

    [Surgical proctology (2)].

    by M Sailer, K H Fuchs, H B Reith, A Thiede

    • 1 January 2000
      • Vol. 125  (7) , W49-52

    [Indications and clinical application of thrombosis prophylaxis. I].

    by U Mittelkötter, H B Reith, A Thiede

    • 1 January 1999
      • Vol. 124  (3) , W19-26

    [Hemotherapy in operative medicine. Part 1].

    by B M Taleghani, H B Reith, D Wiebecke, A Thiede